These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7542226)
1. ras, p53 and HPV status in benign and malignant prostate tumors. Moyret-Lalle C; Marçais C; Jacquemier J; Moles JP; Daver A; Soret JY; Jeanteur P; Ozturk M; Theillet C Int J Cancer; 1995 Apr; 64(2):124-9. PubMed ID: 7542226 [TBL] [Abstract][Full Text] [Related]
2. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. Leiros GJ; Galliano SR; Sember ME; Kahn T; Schwarz E; Eiguchi K BMC Urol; 2005 Nov; 5():15. PubMed ID: 16307686 [TBL] [Abstract][Full Text] [Related]
3. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Anwar K; Nakakuki K; Shiraishi T; Naiki H; Yatani R; Inuzuka M Cancer Res; 1992 Nov; 52(21):5991-6. PubMed ID: 1382850 [TBL] [Abstract][Full Text] [Related]
4. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506 [TBL] [Abstract][Full Text] [Related]
5. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA. Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887 [TBL] [Abstract][Full Text] [Related]
6. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074 [TBL] [Abstract][Full Text] [Related]
7. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus]. Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698 [TBL] [Abstract][Full Text] [Related]
8. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat. Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740 [TBL] [Abstract][Full Text] [Related]
9. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284 [TBL] [Abstract][Full Text] [Related]
10. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Suzuki H; Komiya A; Aida S; Ito H; Yatani R; Shimazaki J Prostate; 1996 May; 28(5):318-24. PubMed ID: 8610059 [TBL] [Abstract][Full Text] [Related]
11. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus. Jiko K; Tsuda H; Sato S; Hirohashi S Int J Cancer; 1994 Dec; 59(5):601-6. PubMed ID: 7960232 [TBL] [Abstract][Full Text] [Related]
12. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network. Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408 [TBL] [Abstract][Full Text] [Related]
13. p53 mutations in sporadic adrenocortical tumors. Ohgaki H; Kleihues P; Heitz PU Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216 [TBL] [Abstract][Full Text] [Related]
14. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977 [TBL] [Abstract][Full Text] [Related]
15. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma. Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299 [TBL] [Abstract][Full Text] [Related]
16. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371 [TBL] [Abstract][Full Text] [Related]
17. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218 [TBL] [Abstract][Full Text] [Related]
18. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Hafkamp HC; Speel EJ; Haesevoets A; Bot FJ; Dinjens WN; Ramaekers FC; Hopman AH; Manni JJ Int J Cancer; 2003 Nov; 107(3):394-400. PubMed ID: 14506739 [TBL] [Abstract][Full Text] [Related]
19. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588 [TBL] [Abstract][Full Text] [Related]
20. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells. Chen TM; Defendi V Oncogene; 1992 Aug; 7(8):1541-7. PubMed ID: 1321402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]